As of 2025-10-15, the Relative Valuation of Immunovant Inc (IMVT) is (83.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.49 USD, the upside of Immunovant Inc based on Relative Valuation is -579.7%.
The range of the Relative Valuation is (82.68) - (89.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.4x - 35.0x | 32.7x |
| Forward P/E multiples | 32.2x - 35.0x | 32.7x |
| Fair Price | (82.68) - (89.76) | (83.91) |
| Upside | -572.7% - -613.2% | -579.7% |
| Date | P/E |
| 2025-10-10 | -6.64 |
| 2025-10-09 | -6.81 |
| 2025-10-08 | -6.26 |
| 2025-10-07 | -6.28 |
| 2025-10-06 | -6.45 |
| 2025-10-03 | -6.59 |
| 2025-10-02 | -6.52 |
| 2025-10-01 | -6.37 |
| 2025-09-30 | -6.28 |
| 2025-09-29 | -6.26 |
| 2025-09-26 | -6.33 |
| 2025-09-25 | -6.11 |
| 2025-09-24 | -6.02 |
| 2025-09-23 | -5.81 |
| 2025-09-22 | -6.08 |
| 2025-09-19 | -5.76 |
| 2025-09-18 | -6.00 |
| 2025-09-17 | -5.89 |
| 2025-09-16 | -5.96 |
| 2025-09-15 | -6.05 |
| 2025-09-12 | -6.30 |
| 2025-09-11 | -6.55 |
| 2025-09-10 | -6.31 |
| 2025-09-09 | -6.39 |
| 2025-09-08 | -6.38 |
| 2025-09-05 | -6.68 |
| 2025-09-04 | -6.28 |
| 2025-09-03 | -6.51 |
| 2025-09-02 | -5.87 |
| 2025-08-29 | -5.72 |
| 2025-08-28 | -5.78 |
| 2025-08-27 | -5.92 |
| 2025-08-26 | -5.88 |
| 2025-08-25 | -5.80 |
| 2025-08-22 | -5.94 |
| 2025-08-21 | -5.78 |
| 2025-08-20 | -5.78 |
| 2025-08-19 | -5.78 |
| 2025-08-18 | -5.95 |
| 2025-08-15 | -5.93 |
| 2025-08-14 | -5.92 |
| 2025-08-13 | -6.19 |
| 2025-08-12 | -5.93 |
| 2025-08-11 | -5.75 |
| 2025-08-08 | -6.02 |
| 2025-08-07 | -6.13 |
| 2025-08-06 | -6.22 |
| 2025-08-05 | -6.43 |
| 2025-08-04 | -6.27 |
| 2025-08-01 | -6.12 |